# Urine Omics Predicting IO Therapy Responses in mUC Patients

> **NCT04641936** · — · RECRUITING · sponsor: **National Taiwan University Hospital** · enrollment: 600 (estimated)

## Conditions studied

- Metastatic Urothelial Carcinoma

## Interventions

- **OTHER:** No intervention required

## Key facts

- **NCT ID:** NCT04641936
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2020-12-17
- **Primary completion:** 2025-10-31
- **Final completion:** 2027-10-31
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2024-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04641936

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04641936, "Urine Omics Predicting IO Therapy Responses in mUC Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04641936. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*